4 pharmas including Hanmi & Green Cross spending more than KRW 100 billion into R&D

Last year, there were 4 listed pharmaceutical companies(Hanmi Pharm, Green Cross, Daewoong Pharmaceutical and Chong Kun Dang) which annually put R&D expenses more than KRW 100 billion.

Including Kwang Dong Pharmaceutical which achieved KRW 1 trillion sales last year, 4 pharmaceutical companies spent less than 1% of their sales into R&D, which shows the intensified polarization in the category....